Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma
Condition(s):ImmunotherapyLast Updated:July 20, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):ImmunotherapyLast Updated:July 20, 2021Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 7, 2020Recruiting
Condition(s):Renal Cancer; Kidney Cancer; Renal Cell Carcinoma; Inferior Vena Cava ThrombosisLast Updated:January 30, 2024Recruiting
Condition(s):Advanced or Metastatic Renal Cell CarcinomaLast Updated:March 21, 2024Recruiting
Condition(s):Renal Neoplasms; Targeted Molecular TherapyLast Updated:February 25, 2016Not yet recruiting
Condition(s):Renal CancerLast Updated:January 24, 2024Recruiting
Condition(s):Kidney Cancer; Renal Cell CarcinomaLast Updated:October 23, 2023Recruiting
Condition(s):Renal Cancer MetastaticLast Updated:February 28, 2023Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma; Clear Cell Renal Cell Carcinoma MetastaticLast Updated:September 26, 2023Recruiting
Condition(s):Metastatic Clear Cell Renal Cell CarcinomaLast Updated:November 18, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.